Janssen Search
Search results
Patience, Perseverance and Partnership
Patience, Perseverance and Partnership We envision a world where cancer is a preventable, chronic or curable disease. To get there, we’re focused on developing solutions that prolong and improve patient lives. In this post, we’re proud to introduce you ...
Alison Chalker, Ph.D.
ALISON CHALKER, PH.D. PORTFOLIO STRATEGY & DATA SCIENCES INTEGRATION LEADER As Strategic Portfolio and Data Sciences Integration Leader for Neuroscience at Janssen Research & Development (R&D), Alison Chalker, Ph.D. leads a team responsible ...
Empowering Black Americans for Greater Clinical Trial Representation
Empowering Black Americans for Greater Clinical Trial Representation In honor of Black History Month, Janssen is spotlighting its commitment to increase diversity among its clinical trial participants, and to expand community engagement to build ...
Our Team: Leading the Fight Against Cancer
Our Team: Leading the Fight Against Cancer At Janssen Oncology, we share a deep passion for scientific innovation and for bringing together the best expertise worldwide to make promising treatments available to patients who are waiting for them. Our ...
ASCO 2020 Virtual Newsroom
With the American Society of Clinical Oncology (ASCO) moving to a virtual platform for its 2020 Annual Meeting, Janssen Oncology remains determined in our efforts to champion science for patients. Thank you for visiting to check out our news from ASCO2020 ...
Kevin Wildenhaus, Ph.D.
As the Behavioral Science Lead for the Disease Interception Accelerator (DIA), Kevin Wildenhaus leads the behavioral science innovation and research efforts for the DIA and its venture focus areas. He is also heading work in perinatal depression to ...
Lloyd S. Miller, M.D., Ph.D.
LLOYD S. MILLER, M.D., PH.D. VICE PRESIDENT IMMUNODERMATOLOGY DISEASE AREA LEADER Lloyd S. Miller, M.D., Ph.D., is Vice President, Immunodermatology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & Development, LLC. In ...
Yusri A. Elsayed, M.D., M.H.Sc., Ph.D.
YUSRI A. ELSAYED, M.D., M.H.Sc., Ph.D. SENIOR VICE PRESIDENT GLOBAL ONCOLOGY THERAPEUTIC AREA HEAD As Global Oncology Therapeutic Area Head for Johnson & Johnson, Yusri Elsayed, M.D., M.H.SC, Ph.D. is responsible for the discovery, development and ...
Dave Yazujian, M.S.
As the Strategy and Operations Support Leader for the Disease Interception Accelerator (DIA), Dave Yazujian drives the development and execution of the DIA strategy, ensuring operational efficiency and effectiveness and integrating input from Janssen ...
Our Work
Article Type: Human Microbiome Institute Our Work We work with our partners to translate exciting ideas into therapies and other health solutions, and to create knowledge and resources that will advance the field as a whole. Our current collaborations ...